With small molecule inhibitors, the inhibition of MALT1 pathway will be partial, and can be titrated based on dose and dose frequency, and thus we believe that the infection risk related to pharmacological MALT1 inhibitors may not be a significant problem. Here, MALT1 is linked to infection.